Background: Progression from anorectal abscess to fistula is poorly described and it remains unclear which patients develop a fistula following an abscess. The aim was to assess the burden of anorectal abscess and to identify risk factors for subsequent fistula formation.
Introduction
Anorectal abscesses are common, with 18 000 patients affected each year in England 1 . The condition is treated primarily by incision and drainage in the operating theatre by a general surgeon. A proportion of patients subsequently develop a fistula; however, estimating the incidence of anal fistula is difficult and current evidence is inconsistent. Sainio 2 derived the incidence of anal fistula from operating room data in a single institution in Helsinki between 1969 and 1978; the incidence was 8⋅6 per 100 000 population per year (12⋅6 per 100 000 for males and 5⋅6 per 100 000 for females) 2 . Zanotti and colleagues 3 reported a higher incidence, but this was estimated from data from a single year; based on a review of European databases the incidence was 1⋅84 per 10 000 in the UK (2003) (2004) and 2⋅32 per 10 000 in Italy (2002). The cryptoglandular hypothesis proposes that infection of an intersphincteric gland via an internal opening leads to fistulation out to the perianal skin. However, not all anorectal abscesses lead to persistent fistulas. Oliver and co-workers 4 reported that 83 per cent of 200 abscesses had an internal opening when examined by an experienced proctologist. Treating fistulas in the acute phase reduced the recurrence rate (from 29 to 5 per cent), demonstrating that not all patients who had abscesses with an internal opening subsequently presented with a fistula. Read and Abcarian 5 similarly found that 40 per cent of abscesses progressed to fistula formation, but other studies 6 -11 reported rates ranging from 26 to 87 per cent. This was even the case in studies in which abscesses in all patients had an internal opening (acute fistula) 12, 13 . This means that some patients with abscesses associated with an internal opening would never present with a persistent fistula 14 . Treating the fistula in the acute phase also risks iatrogenic injury, either to the sphincter or by the creation of new tracts.
It would be helpful to stratify patients with an abscess according to risk of presenting with a persistent fistula 15 . Other than Crohn's disease, there are few reliable clinical factors that predict which abscesses will develop into fistulas 16 . It is important to be able to predict which abscesses are likely to fistulate, so clinicians can make informed follow-up plans. Follow-up after abscess is clinician-dependent; most simple abscesses are not followed up. Understanding which patients are more likely to develop fistulation will allow clinicians to follow up those at high risk of fistula development and prevent complications 15 .
Between 28 and 38 per cent of patients with Crohn's disease suffer from perianal disease 17, 18 . Perianal Crohn's disease is associated with a higher rate of fistula recurrence following treatment and a shorter median time to recurrence 2, 3 . It represents a distinct and aggressive phenotype 19 and is one of the most disabling manifestations of Crohn's disease 20 ; 12-39 per cent of patients with perianal Crohn's disease undergo proctectomy for intractable proctitis 21 -24 . Early identification of patients with perianal Crohn's disease is important to avoid complications.
The aim of this population-based study was to assess the burden of new diagnosis of anorectal abscess and identify risk factors that lead to subsequent fistula formation.
Methods
Ethical approval for the study was obtained through the National Research Ethics Service (project ID 134045, Research Ethics Committee reference 13/LO/1235) and local Research and Development permission was sought (reference 13.051) from London North West Hospitals NHS Trust.
Hospital Episode Statistics (HES) is an administrative data set with almost complete capture of all hospital episodes in England since its inception in 1987. Within the data set, diagnoses are coded according to the WHO ICD-10 classification. The diagnostic codes and operative codes used to identify abscess, fistula and inflammatory bowel disease (IBD) are shown in Table 1 . Patients were identified according to these codes, capturing inpatient, outpatient and emergency attendances. The HES data set from April 1997 to March 2012 was analysed. The first patient admission with an abscess code was taken as the index abscess admission. Patients admitted to hospital owing to an anal abscess or fistula before or at the same time as their index abscess admission were excluded from the study. Age and social deprivation data were also obtained. Deprivation was assessed using the Indices of Multiple Deprivation, a measure of relative levels of deprivation, classified in quintiles (Q1, most affluent; Q5, most deprived). Pre-existing co-morbidity was evaluated using the Charlson Co-morbidity Index. The time from admission with an abscess to the development of a fistula was calculated. Censoring of patients was carried out as follows. For patients in whom fistula formation following abscess drainage occurred, the admission date for the first episode with a fistula after an abscess episode was taken as the censor date. Patients who did not have a fistula episode were censored at the date of death (if applicable) or the last admission date for the data set (31 March 2012).
Statistical analysis
Groups were compared using Kruskal-Wallis analyses. Binary logistic regression and Cox proportional hazard regression models were developed to determine factors associated with progression from abscess to fistula. Variables were individually tested initially against the outcome (progress to fistula from abscess). Kaplan-Meier methodology was used to assess fistula rates over time. Variables with P ≤ 0⋅001 were considered significant and entered into a multivariable (adjusted) regression model. In multivariable analyses, factors with P ≤ 0⋅050 were considered statistically significant. All statistical analyses were carried out using SPSS ® version 21.0 (IBM, Armonk, New York, USA). multiple deprivation. The 6823 patients (4⋅1 per cent) with incomplete data were excluded from the study. The median follow-up time for the whole cohort was 60 (i.q.r. 17-115) months. The majority of patients were men (110 012, 69⋅3 per cent) and the most commonly coded abscess type was perianal (136 021, 85⋅7 per cent).
Results

A total of
The median age at the time of first presentation with an abscess was 40 (i.q.r. 29-52) years. Abscesses were most commonly identified in the 41-60-year age group. The majority of fistula episodes were in men (65⋅3 per cent). Some 12 158 patients (7⋅7 per cent) had a diagnosis of diabetes before their first admission with an abscess, and 7571 (4⋅8 per cent) had a diagnosis code for Crohn's disease at some point in the study interval ( Table 2) .
Incidence of abscess
The crude incidence rate of first admission to hospital with an abscess in the study was 20⋅4 per 100 000 over 15 years 
Values in parentheses are 95 per cent confidence intervals. IBD, inflammatory bowel disease.
20⋅3) per 100 000. The age standardized rate does not include the significant number of patients with recurrent abscesses or patients treated in the private sector.
Incidence and timing from abscess to fistula
Over the 15 years, the overall rate of fistula formation, as defined by ICD-10 and OPCS codes, following anorectal abscess was 17⋅2 per cent (27 349 of 158 713). Subclassification by IBD status revealed that the rate of fistula formation following an abscess was 15⋅5 per cent (23 012 of 148 286) in idiopathic cases and 41⋅6 per cent (4337 of 10 427) among patients with IBD (26⋅7 per cent coded concurrently as ulcerative colitis; 47⋅2 per cent coded as Crohn's disease).
Across the study population, of the 27 349 patients in whom a perianal abscess progressed to fistula, it did so within 12 months in 18 469 (67⋅5 per cent). In a stratified analysis using Kaplan-Meier methodology, among the non-IBD population, 15 623 of 29 724 patients (52⋅6 (95 per cent c.i. 51⋅6 to 53⋅0) per cent) progressed to fistula from anorectal abscess within 12 months. This rate of progression from anorectal abscess to fistula was higher in those with ulcerative colitis, of whom 537 of 824 patients (65⋅2 (61⋅4 to 68⋅1) per cent) progressed, and higher still in patients with Crohn's disease, of whom 2309 of 2747 patients (84⋅1 (82⋅6 to 85⋅9) per cent) progressed within 12 months (all P < 0⋅001) (Figs 1 and 2) .
Timing of fistula diagnosis
The median time to first episode (inpatient, outpatient, or accident and emergency) of fistula following abscess drainage was 7⋅0 (i.q.r. 6⋅9-7⋅1) months for patients who developed a fistula. Of patients diagnosed with a fistula within 1 year, the median time to fistulation was 7⋅0 (95 per cent c.i. 6⋅9 to 7⋅1) months for the idiopathic cohort, 5⋅0 (4⋅5 to 5⋅5) months for patients with ulcerative colitis 
Factors associated with fistula
Cox proportional hazards regression analyses was undertaken to identify factors associated with diagnosis of a fistula after first admission with an abscess (Table 3) . Independent predictors of fistulation were female sex (hazard ratio (HR) 1⋅18, 95 per cent c.i. 1⋅15 to 1⋅21; P < 0⋅001), age 41-60 years (HR 1⋅85, 1⋅76 to 1⋅95; P < 0⋅001), and ischiorectal (HR 1⋅48, 1⋅43 to 1⋅53; P < 0⋅001) or intersphincteric (HR 1⋅53, 1⋅38 to 1⋅70; P < 0⋅001) location of the initial abscess. The presence of IBD was particularly strongly associated with progression to fistula compared with idiopathic disease (ulcerative colitis: HR 1⋅82, 1⋅69 to 1⋅96, P < 0⋅001; Crohn's disease: HR 3⋅51, 3⋅38 to 3⋅63, P < 0⋅001).
Diabetes, an existing co-morbidity or a social deprivation quintile greater than Q1 were not associated with an increased risk of fistula formation.
Diagnosis of Crohn's disease in relation to anorectal sepsis
Some 7571 patients in the cohort (4⋅8 per cent) had Crohn's disease. An established diagnosis of Crohn's disease before the first admission with an anorectal abscess was recorded in 3218 patients (42⋅5 per cent). A further 1209 patients (16⋅0 per cent) were diagnosed with Crohn's disease within their admission for the first abscess. The remaining 3144 patients (41⋅5 per cent) had a diagnostic code for Crohn's disease at a median of 14 (i.q.r. 4-40) months after their first abscess (Fig. 3) .
Of the 3144 patients with Crohn's disease diagnosed after their abscess admission, 1725 (54⋅9 per cent) went on to develop a fistula within the study period. The median time to diagnosis of the 958 patients who were diagnosed with Crohn's disease after the fistula admission was 5 (i.q.r.
2-20) months.
Of the 158 713 patients presenting with an anorectal abscess, 155 495 were not known to have Crohn's disease before admission. Of these, 4353 (2⋅8 per cent) were subsequently diagnosed with Crohn's disease, either at the time of admission or subsequent to their admission with an anorectal abscess.
Discussion
In this observational population-based study, the incidence (age-standardized rate) of first admission with an abscess was 20⋅2 per 100 000 in England. Anorectal abscesses were common, with approximately one-fifth of all patients with an abscess going on to develop a fistula. The majority of fistulas occurred within the first year of the preceding abscess and this was most pronounced in patients with Crohn's disease. Nearly half of all patients with Crohn's abscesses developed a fistula.
The true incidence of both abscess and fistula is poorly defined in the literature 15 . The incidence in the present study is an accurate reflection for new abscesses in England, but does not include recurrent abscesses or those in patients presenting to the private sector. Current understanding suggests that the male population has a higher incidence of abscess and fistula 25 , the male : female ratio is in the order of 2 : 1. Here, of patients with abscesses, 69⋅3 per cent were men. Of those who went on to develop a fistula, two-thirds were men. Based on the present analysis, the mean annual number of new diagnoses of abscess was 10 580 in a population of 53⋅0 million 26 . From the new abscess diagnoses, an overall incidence of abscess of 298⋅9 per 100 000 can be derived. [Correction added on 13 September 2017, after first online publication: 'incidence of fistula' has been corrected to 'incidence of abscess'] This, however, underestimates the true burden, as it does not include recurrent presentations with abscesses.
Analysis according to type of IBD revealed that almost one-half of patients with Crohn's abscesses (47⋅2 per cent) and one-quarter of those with ulcerative colitis (26⋅7 per cent) went on to be diagnosed with a fistula. Following an abscess, the majority of subsequent fistula presentations occurred within the first year. The data do not allow calculation of the incidence of anorectal disease in IBD, but do confirm that abscesses in patients with IBD are more likely to fistulate. The exact pathogenesis of fistulas is less clearly defined in IBD. The cause is likely to be multifactorial, including genetic, immunological and microbiological factors. In addition to suppuration from anal glands, other aetiological theories have been proposed, such as fistulas arising as a result of a deep penetrating ulcer in the anorectum 20 . Patients with Crohn's disease had an accelerated diagnosis of fistula, with the median time to diagnosis decreasing from 7 to 5 months.
Although a high risk of underlying fistula may be expected in the Crohn's cohort, an interesting observation is the rate of fistula formation among patients with ulcerative colitis. For the purpose of interpretation, if a patient had a diagnostic code for Crohn's disease at any point during the study, this was the final IBD diagnosis recorded, in an effort to mitigate the argument that some patients actually had Crohn's disease and were misdiagnosed as having ulcerative colitis. Nevertheless, misdiagnosis remains a possibility and the development of perianal disease in a patient with a known diagnosis of ulcerative colitis should prompt clinicians to review the IBD status, and investigate the possibility that the true diagnosis is Crohn's disease. Concomitant perianal disease has been described in 5 per cent of patients with ulcerative colitis by Zabana and colleagues 27 . Another possible hypothesis for the increased rate of fistula formation in patients with ulcerative colitis is that a combination of the systemic nature of the disease and immunosuppressant medications might lead to an increase in the formation of cryptoglandular-type fistulas.
The present data showed a higher incidence of fistula in men but, surprisingly, women were 18 per cent more likely to develop a fistula following an abscess. A similar association was found in a study 28 of 146 patients, which reported a higher incidence of fistula formation in females, particularly for anterior abscesses. However, the study contained only 44 female patients and regression analysis was not applied. The authors also found that there was no difference in bacterial growth by sex 28 . They hypothesized that anatomical differences might explain the higher incidence of anterior abscesses. Other hypotheses include inadequate incision and drainage in the first instance or higher rates of anal digitation in women, but these need validation.
The majority of the abscesses in the present study were coded as perianal, but the anatomical classification of abscesses was determined by the operating surgeon. This is often a junior trainee, who may use 'perianal' as an umbrella term in place of 'anorectal'. The incidence of fistula development was higher in patients who presented with ischiorectal and intersphincteric abscesses. Given the significant preponderance of abscesses coded as perianal in the present study, this result must be interpreted with caution. However, Sözener and co-workers 29 also found that ischiorectal (odds ratio 7⋅82) and intersphincteric (odds ratio 3⋅35) abscesses had a higher risk of progression to fistula than perianal abscesses.
The relationship between socioeconomic status and fistula formation followed an almost linear trend from Q1 to Q5, with patients in the Q1 (affluent) socioeconomic group having both a higher proportion of perianal sepsis and a greater tendency to fistula formation. This raises the question of how socioeconomic status might be related to abscess/fistula presentation. It is not possible to draw any conclusions from the present data, but the greater tendency reported could be related to behavioural patterns and/or access to healthcare.
Perhaps unsurprisingly, diabetes was not associated with fistula formation, diabetes being a precursor to cutaneous infections. Patients with type 1 diabetes were less likely to present with a fistula after drainage of an abscess. In a univariable analysis, Hamadani and co-workers 30 reported that patients with diabetes had a twofold increased risk of anorectal sepsis recurrence compared with those without diabetes. Yano et al. 31 noted that diabetes was not a risk factor for abscess recurrence.
Anal sepsis has been found to be the initial manifestation and the presenting complaint in 10-25 per cent of Crohn's diagnoses 17, 32 . A more recent population-based cohort study 33 noted that up to one-fifth of patients develop perianal disease at least 6 months before luminal disease. In the present study, approximately three in every 100 patients presenting with an anorectal abscess went on to a diagnosis of Crohn's disease. The median time to diagnosis was just over 1 year. More than half of these patients without a Crohn's diagnosis at the time of admission for abscess subsequently developed a fistula. In luminal disease, there is a benefit in initiating earlier biological therapy in appropriate patients 34, 35 ; this has been shown to increase the remission rate 36 . In perianal disease, the impact of a delay in diagnosis on outcomes is not known, but it is likely to be detrimental given that perianal Crohn's disease represents a severe phenotype.
Although previous studies have demonstrated the high diagnostic accuracy of routinely collected clinical data 37 , as with any retrospective administrative study there is a potential for coding error. This may be a problem particularly in determining the site of abscess. Furthermore, in this study, the first admission with an abscess was taken as an index admission for abscess and it was assumed that neither fistula nor abscess had occurred previously. It is possible that some patients (especially those with an index admission at the beginning of the data set in 1997) might have had an abscess/fistula previously that would not be captured by the present data. The HES database does not contain information on other confounders (for example smoking status) or the role of drugs such as antitumour necrosis factor agents and immunosuppressants. This study has provided an estimation of the incidence of fistula arising from an abscess in the English National Health Service, but this will be different from that in countries where there is no universal healthcare access or where the management of perianal abscess differs.
Although HES data have inherent limitations, there are important messages to be taken from this analysis. This large population-based study reports a large number of observations over 15 years with almost complete data capture. The results indicate that approximately one-fifth of all patients develop a fistula following an abscess; women have the greatest risk, although both abscess and fistula are more common in men. Nearly half of all patients with Crohn's abscesses develop a fistula, the majority occurring within 12 months. Some 2⋅8 per cent of patients without a diagnosis of Crohn's disease at the time of admission for anorectal abscess will be found to have the disease after a median of 14 months.
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